NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program

Core Viewpoint - The company is pausing the introduction of US-produced products, including its Florida Sunshine brand of vitamins and supplements, in China due to the impact of increased tariffs, while continuing to sell OPKO-branded products that are not subject to these tariffs [1][2][3]. Group 1: Impact of Tariffs - The company expects a material impact on anticipated sales of US products into China due to the escalation of tariffs on US goods [1]. - The pause in initiatives is specifically related to the e-Commerce development program aimed at helping US businesses access the Chinese market through platforms like Alibaba's Tmall [2]. Group 2: Product Strategy - The company will continue selling OPKO Health Europe products in China, which include nutraceuticals and supplements, as these products are not produced in the US and thus are not affected by the tariffs [3]. - The company is exploring opportunities to sell Florida Sunshine products in other markets outside of China [2]. Group 3: Company Overview - NextPlat Corp is a global e-commerce platform that aims to capitalize on high-growth sectors, including technology and healthcare, through various business strategies such as acquisitions and joint ventures [4]. - The company operates an e-commerce communications division and provides pharmacy and healthcare data management services in the US through its subsidiary, Progressive Care LLC [4].